254 related articles for article (PubMed ID: 26496997)
1. [Hepatocellular tumours in noncirrhotic liver tissue].
Goltz D; Fischer HP
Pathologe; 2015 Nov; 36(6):597-606; quiz 607-8. PubMed ID: 26496997
[TBL] [Abstract][Full Text] [Related]
2. Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions.
Wang HL; Anatelli F; Zhai QJ; Adley B; Chuang ST; Yang XJ
Arch Pathol Lab Med; 2008 Nov; 132(11):1723-8. PubMed ID: 18976006
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical approach for the diagnosis of a liver mass on small biopsy specimens.
Choi WT; Ramachandran R; Kakar S
Hum Pathol; 2017 May; 63():1-13. PubMed ID: 28087475
[TBL] [Abstract][Full Text] [Related]
4. [Preneoplasia of the liver. Definition--differential diagnosis--clinical consequences].
Tannapfel A; Wittekind C
Pathologe; 2001 Nov; 22(6):399-406. PubMed ID: 11766639
[TBL] [Abstract][Full Text] [Related]
5. [Highly differentiated hepatocellular tumors. Concepts, criteria, and differential diagnosis].
Schrimacher P; Prange W; Dries V; Dienes HP
Pathologe; 2001 Nov; 22(6):407-16. PubMed ID: 11766640
[TBL] [Abstract][Full Text] [Related]
6. Pathological diagnosis of benign hepatocellular nodular lesions based on the new World Health Organization classification.
Kondo F; Fukusato T; Kudo M
Oncology; 2014; 87 Suppl 1():37-49. PubMed ID: 25427732
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic utility and limitations of glutamine synthetase and serum amyloid-associated protein immunohistochemistry in the distinction of focal nodular hyperplasia and inflammatory hepatocellular adenoma.
Joseph NM; Ferrell LD; Jain D; Torbenson MS; Wu TT; Yeh MM; Kakar S
Mod Pathol; 2014 Jan; 27(1):62-72. PubMed ID: 23807780
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.
Shafizadeh N; Genrich G; Ferrell L; Kakar S
Hum Pathol; 2014 May; 45(5):976-83. PubMed ID: 24746201
[TBL] [Abstract][Full Text] [Related]
9. Focal nodular hyperplasia or focal nodular hyperplasia-like lesions of the liver: a special emphasis on diagnosis.
Choi JY; Lee HC; Yim JH; Shim JH; Lim YS; Shin YM; Yu ES; Suh DJ
J Gastroenterol Hepatol; 2011 Jun; 26(6):1004-9. PubMed ID: 21251063
[TBL] [Abstract][Full Text] [Related]
10. [Recent developments in biopsy diagnosis of early and undefined liver tumors].
Longerich T; Schirmacher P
Z Gastroenterol; 2009 Jan; 47(1):30-6. PubMed ID: 19156590
[TBL] [Abstract][Full Text] [Related]
11. Focal nodular hyperplasia-like areas in cirrhosis.
Quaglia A; Tibballs J; Grasso A; Prasad N; Nozza P; Davies SE; Burroughs AK; Watkinson A; Dhillon AP
Histopathology; 2003 Jan; 42(1):14-21. PubMed ID: 12493020
[TBL] [Abstract][Full Text] [Related]
12. Noncirrhotic hepatocellular carcinoma: derivation from hepatocellular adenoma? Clinicopathologic analysis.
Liu TC; Vachharajani N; Chapman WC; Brunt EM
Mod Pathol; 2014 Mar; 27(3):420-32. PubMed ID: 24051694
[TBL] [Abstract][Full Text] [Related]
13. [Study on the morphological features, pathologic diagnosis and differential diagnosis of well-differentiated hepatocellular carcinoma].
Wei L; Du J; Wang Y; Shi H; Zhao J
Zhonghua Bing Li Xue Za Zhi; 2014 Jul; 43(7):459-62. PubMed ID: 25327795
[TBL] [Abstract][Full Text] [Related]
14. Macroregenerative nodules in cirrhosis are not associated with elevated serum or stainable tissue alpha-fetoprotein.
Theise ND; Fiel IM; Hytiroglou P; Ferrell L; Schwartz M; Miller C; Thung SN
Liver; 1995 Feb; 15(1):30-4. PubMed ID: 7539880
[TBL] [Abstract][Full Text] [Related]
15. Utility of CD34 reactivity in evaluating focal nodular hepatocellular lesions sampled by fine needle aspiration biopsy.
Kong CS; Appenzeller M; Ferrell LD
Acta Cytol; 2000; 44(2):218-22. PubMed ID: 10740609
[TBL] [Abstract][Full Text] [Related]
16. [Highly differentiated liver tumors: recent developments and their diagnostic application].
Schirmacher P; Longerich T
Pathologe; 2009 Dec; 30 Suppl 2():200-6. PubMed ID: 19908045
[TBL] [Abstract][Full Text] [Related]
17. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver.
Holland AE; Hecht EM; Hahn WY; Kim DC; Babb JS; Lee VS; West AB; Krinsky GA
Radiology; 2005 Dec; 237(3):938-44. PubMed ID: 16306035
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical stains of proliferating cell nuclear antigen, insulin-like growth factor 2 and clusterin help distinguish malignant from benign liver nodular lesions.
Lai JP; Chen ZM; Lok T; Chan OT; Himmelfarb E; Zhai Q; Lin F; Wang HL
J Clin Pathol; 2014 Jun; 67(6):464-9. PubMed ID: 24407433
[TBL] [Abstract][Full Text] [Related]
19. [Macronodules, dysplastic nodules and cirrhosis].
Cochand-Priollet B; Fabre M
J Radiol; 2001 Mar; 82(3 Pt 1):215-9. PubMed ID: 11287851
[TBL] [Abstract][Full Text] [Related]
20. Differential diagnosis of hepatocellular nodular lesions.
Hytiroglou P; Theise ND
Semin Diagn Pathol; 1998 Nov; 15(4):285-99. PubMed ID: 9845429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
